Canada markets closed

Deciphera Pharmaceuticals, Inc. (DCPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.36-0.01 (-0.04%)
At close: 04:00PM EDT
25.35 -0.01 (-0.04%)
After hours: 07:12PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.09B
Enterprise Value 1.80B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)13.21
Price/Book (mrq)5.94
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.20
52-Week Change 378.34%
S&P500 52-Week Change 326.27%
52 Week High 325.55
52 Week Low 39.90
50-Day Moving Average 317.44
200-Day Moving Average 314.66

Share Statistics

Avg Vol (3 month) 31.6M
Avg Vol (10 day) 37.39M
Shares Outstanding 582.23M
Implied Shares Outstanding 686.48M
Float 841.96M
% Held by Insiders 129.96%
% Held by Institutions 174.78%
Shares Short (Apr 15, 2024) 45.75M
Short Ratio (Apr 15, 2024) 410.9
Short % of Float (Apr 15, 2024) 49.98%
Short % of Shares Outstanding (Apr 15, 2024) 47.00%
Shares Short (prior month Mar 15, 2024) 45.65M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -119.34%
Operating Margin (ttm)-106.10%

Management Effectiveness

Return on Assets (ttm)-28.43%
Return on Equity (ttm)-56.29%

Income Statement

Revenue (ttm)163.36M
Revenue Per Share (ttm)1.92
Quarterly Revenue Growth (yoy)32.90%
Gross Profit (ttm)N/A
EBITDA -208.86M
Net Income Avi to Common (ttm)-194.94M
Diluted EPS (ttm)-2.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)306.22M
Total Cash Per Share (mrq)3.79
Total Debt (mrq)25.88M
Total Debt/Equity (mrq)7.37%
Current Ratio (mrq)3.80
Book Value Per Share (mrq)4.36

Cash Flow Statement

Operating Cash Flow (ttm)-146.7M
Levered Free Cash Flow (ttm)-72.79M